Institute for Neurodegenerative Disorders — New Haven, Connecticut

Institute for Neurodegenerative Disorders is a clinical research site located in New Haven, Connecticut, United States 06510.

Crixeo Clinical Trials Trust Score: 28/100 (FAILING). This profile has not yet been claimed by the site owner.

Institute for Neurodegenerative Disorders has participated in 75 clinical trials with 7 currently active.

Therapeutic areas: Alzheimer's Disease, Parkinson Disease, Neurodegenerative Diseases.

Sponsors: Eli Lilly and Company, Institute for Neurodegenerative Disorders, Michael J. Fox Foundation for Parkinson's Research.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in New Haven

Browse all research sites in Connecticut · View every site in New Haven

Sponsor Feasibility Report

Trust Score: 28/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Institute for Neurodegenerative Disorders?

Institute for Neurodegenerative Disorders has a Crixeo Trust Score of 28/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Institute for Neurodegenerative Disorders conducted?

Institute for Neurodegenerative Disorders has 75 clinical trials on record, with 7 currently active. Their work covers Alzheimer's Disease, Parkinson Disease, Neurodegenerative Diseases.

Is Institute for Neurodegenerative Disorders accredited by Crixeo Clinical Trials?

Institute for Neurodegenerative Disorders has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Institute for Neurodegenerative Disorders?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.